Ligand Pharmaceuticals Incorporated beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $1.21 | — | — | Miss |
| Q1 FY2026 | $1.84 | — | — | Miss |
| Q12026 FY2026 | $0.98 | $-0.67 | -168.4% | Miss |
| 2026-02-26 | $1.46 | — | — | Miss |
Back to LGND overview · LGND holders · LGND KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.